Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN Fornerod M, Boer J, van Baal S, Morreau H, Grosveld G.

The human CAN gene was first identified as a target of t(6;9)(p23;q34), associated with acute myeloid leukemia and myelodysplastic syndrome, which results in the expression of a DEK-CAN fusion gene  Boer J, Bonten-Surtel J, Grosveld G.

Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN Fornerod M, Boer J, van Baal S, Morreau H, Grosveld G.

Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9)(p23;q34) and the expression of dek-can chimaeric transcript.  Hamaguchi H, Nagata K, Yamamoto K, Fujikawa I, Kobayashi M, Eguchi M.

An integrated map of human chromosome 6p23.  Olavesen MG, Davies AF, Broxholme SJ, Wixon JL, Senger G, Nizetic D, Campbell RD, Ragoussis J.

DEK is an autoantigen in juvenile rheumatoid arthritis  Sierakowska H, Williams KR, Szer IS, Szer W.

Dek-can rearrangement in translocation (6;9)(p23;q34)  Soekarman D, von Lindern M, van der Plas DC, Selleri L, Bartram CR, Martiat P, Culligan D, Padua RA, Hasper-Voogt KP, Hagemeijer A, et al.

The translocation (6;9), associated with a specific subtype of acute myeloid leukemia   von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A, Grosveld G.

Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma  Potter MN, Cross NC, van Dongen JJ, Saglio G, Oakhill A, Bartram CR, Goldman JM.

Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation  Deininger MW, Bose S, Gora-Tybor J, Yan XH, Goldman JM, Melo JV.

Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma  Potter MN, Cross NC, van Dongen JJ, Saglio G, Oakhill A, Bartram CR, Goldman JM.

DEK an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer  Fu GK, Grosveld G, Markovitz DM.

Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene.  von Lindern M, Fornerod M, Soekarman N, van Baal S, Jaegle M, Hagemeijer A, Bootsma D, Grosveld G.

The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner  Alexiadis V, Waldmann T, Andersen J, Mann M, Knippers R, Gruss C.

DEK forms a splicing-dependent interaction with exon-product complexes  McGarvey T, Rosonina E, McCracken S, Li Q, Arnaout R, Mientjes E, Nickerson JA, Awrey D, Greenblatt J, Grosveld G, Blencowe BJ.

Protein encoded by the proto-oncogene DEK, which is involved in acute myelogenous leukemia, induces alterations of the superhelical density of DNA in chromatin  Alexiadis V, Waldmann T, Andersen J, Mann M, Knippers R, Gruss C.

Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide  Ohminami H, Yasukawa M, Kaneko S, Yakushijin Y, Abe Y, Kasahara Y, Ishida Y, Fujita S.

DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer Fu GK, Grosveld G, Markovitz DM.

The translocation (6;9)(p23;q34) is mainly found in specific subtypes of acute myeloid leukemia Soekarman D, von Lindern M, van der Plas DC, Selleri L, Bartram CR, Martiat P, Culligan D, Padua RA, Hasper-Voogt KP, Hagemeijer A, et al.